Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-25 Longitude Capital Partners II, LLC 10% owner Conversion +2,055,946 2,055,946
2017-07-25 Longitude Capital Partners II, LLC 10% owner Purchase +215,000 $15.00 $3.2M 2,270,946
2017-07-25 Longitude Capital Partners II, LLC 10% owner Conversion · Series C Preferred Stock −10,707,985 0
2017-07-25 ORBIMED ADVISORS LLC 10% owner Conversion +2,055,946 2,055,946
2017-07-25 ORBIMED ADVISORS LLC 10% owner Purchase +319,333 $15.00 $4.8M 2,375,279
2017-07-25 ORBIMED ADVISORS LLC 10% owner Conversion · Series C Preferred Stock −10,707,985 0
2017-07-25 Paull Robert Bradley Director Conversion +1,204,937 1,204,937
2017-07-25 Paull Robert Bradley Director Conversion · Series Seed Preferred Stock −3,677,373 0
2017-07-25 Paull Robert Bradley Director Conversion · Series A Preferred Stock −1,666,666 0
2017-07-25 Paull Robert Bradley Director Conversion · Series B Preferred Stock −900,146 0
2017-07-25 Paull Robert Bradley Director Conversion · Series C Preferred Stock −31,494 0
2017-07-25 Paull Robert Bradley Director Conversion · Series B Preferred Stock Warrant (right to buy) −84,130 0
2017-07-25 Paull Robert Bradley Director Conversion · Common Stock Warrant (right to buy) +16,152 16,152
2017-07-25 Grunberg Gregory Director Conversion +2,055,946 2,055,946
2017-07-25 Grunberg Gregory Director Purchase +215,000 $15.00 $3.2M 2,270,946
2017-07-25 Grunberg Gregory Director Conversion · Series C Preferred Stock −10,707,985 0
2017-07-25 Shah Rajeev M. Director Conversion +1,579,903 1,579,903
2017-07-25 Shah Rajeev M. Director Purchase +533,333 $15.00 $8.0M 2,113,236
2017-07-25 Shah Rajeev M. Director Conversion · Series B Preferred Stock −3,819,444 0
2017-07-25 Shah Rajeev M. Director Conversion · Series C Preferred Stock −4,409,170 0

Page 22 of 24 · 472 trades